[13] Reduced Inflammation : PeptiStrong contains bioactive peptides that decrease TNF- secretion, helping to reduce inflammation that can contribute to muscle breakdown
These agents, which have shown efficacy in non-transplant populations, present new opportunities for improving the management of diabetes mellitus in liver transplant recipients, potentially mitigating the adverse effects of PTDM and enhancing long-term outcomes
Eichenberger, M
Schwartz, M., Woods, S., Porte, D., Seeley, R
The most common side effects are gastrointestinal and tend to improve after the first few weeks: Nausea, vomiting, or diarrhea (most common, especially early on) Constipation or stomach discomfort Reduced appetite Less common but serious side effects include pancreatitis, gallbladder issues, and low blood sugar particularly in patients taking diabetes medications
the disulfide bond is sensitive to strongly reducing conditions